Medytox Archives | Be Korea-savvy
Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants

Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants

JUPITER, Fla., March 22 (Korea Bizwire) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and therapeutics at flexible commercial scales, [...]

ITC Favors Medytox over Daewoong in Botulinum Toxin Strain Dispute in Final Ruling

ITC Favors Medytox over Daewoong in Botulinum Toxin Strain Dispute in Final Ruling

SEOUL, Dec. 17 (Korea Bizwire) — A U.S. trade panel has upheld its preliminary ruling by siding with South Korean drugmaker Medytox Inc. in a trade dispute, saying its local rival Daewoong Pharmaceutical Co. copied the manufacturing process of a botulinum toxin strain, industry officials here said Thursday. In a final decision, the U.S. International [...]

S. Korean Pharmaceutical Companies in a Prolonged ‘War on Botox’

S. Korean Pharmaceutical Companies in a Prolonged ‘War on Botox’

SEOUL, May 20 (Korea Bizwire) — As the ‘war on botox strains’ is escalating between Medytox Inc. and Daewoong Pharmaceutical Co., the tension between the two companies is becoming worse day by day. Medytox has filed a complaint with the U.S. International Trade Commission (USITC), accusing Daewoong of stealing the company’s botox strains. Daewoong has [...]

Medytox Files Lawsuit Against Daewoong Pharmaceuticals Over Botox Substance

Medytox Files Lawsuit Against Daewoong Pharmaceuticals Over Botox Substance

SEOUL, Oct. 31 (Korea Bizwire) – South Korean pharmaceutical firms Medytox and Daewoong Pharmaceuticals are heading to court to settle a dispute surrounding the use of botulinum toxin, a highly poisonous substance used to make Botox, with the South Korean media branding the legal battle as the ‘Botox War’. According to Medytox on Monday, the pharmaceutical [...]

Competition in Botox Market Turns Ugly

Competition in Botox Market Turns Ugly

SEOUL, Oct. 14 (Korea Bizwire) – The market for botulinum toxin (BTX), commonly marketed as botox, is rapidly expanding in Korea. But fierce competition between Korean botox distributors has recently intensified, with businesses questioning the safety of each other’s products.  There are currently seven BTX distributors globally, three of which are Korean – Medytox, Hugel, [...]